Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Kenneth Alper"'
Autor:
Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen, K. Yaragudri Vinod
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
The classical psychedelic psilocybin is of interest as a treatment for alcohol use disorder (AUD). This study investigated the effects of psilocybin on voluntary ethanol consumption in adult male and female C57BL/6J mice administered saline or psiloc
Externí odkaz:
https://doaj.org/article/b63a0aa0c7e6412f88a5a373fcf9c5da
Autor:
Kenneth Alper
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Famotidine is of interest as a possible treatment for COVID-19, with effects on disease-related symptoms and survival reported in observational and retrospective studies, as well as in silico predictions of binding to potential SARS-CoV-2 drug target
Externí odkaz:
https://doaj.org/article/77bfdf84273e423da2488b3a5b89c008
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
There is a substantive clinical literature on classical hallucinogens, most commonly lysergic acid diethylamide (LSD) for the treatment of alcohol use disorder. However, there has been no published research on the effect of LSD on alcohol consumption
Externí odkaz:
https://doaj.org/article/4b03ac551a8646ba937faa5c28908e46
Autor:
Tamara Antonio, Steven R Childers, Richard B Rothman, Christina M Dersch, Christine King, Martin Kuehne, William G Bornmann, Amy J Eshleman, Aaron Janowsky, Eric R Simon, Maarten E A Reith, Kenneth Alper
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77262 (2013)
The iboga alkaloids are a class of small molecules defined structurally on the basis of a common ibogamine skeleton, some of which modify opioid withdrawal and drug self-administration in humans and preclinical models. These compounds may represent a
Externí odkaz:
https://doaj.org/article/15dd1576a36a4ceaa239a8d0e66074b4
Autor:
Nian Liu, Rong Bai, Xi Ping Huang, Steven J. Fowler, Silvia G. Priori, Yanfei Ruan, Kenneth Alper
Publikováno v:
Cardiovascular Toxicology. 16:14-22
The iboga alkaloids are a class of naturally occurring and synthetic compounds, some of which modify drug self-administration and withdrawal in humans and preclinical models. Ibogaine, the prototypic iboga alkaloid that is utilized clinically to trea
Autor:
Jesse G. Brand, William B. Barr, Kenneth Alper, Sarah G. Schaffer, Orrin Devinsky, Monica Rivera Mindt
Publikováno v:
Epilepsy & Behavior. 25:552-557
The current study examined whether mood-congruent biases in emotion processing extend to epilepsy patients with depressive symptoms and the potentially moderating effects of age of seizure onset on these biases. In addition, we examined associations
Autor:
Jignasa G. Patel, Kenneth Alper, William B. Barr, Ruben Kuzniecky, K. Starner, Angela L. Carrelli, Peter L. Flom, Chad Carlson, Orrin Devinsky, Charles Kyriakos Vorkas
Publikováno v:
Annals of Neurology. 63:602-610
Objective Divergent findings among prior studies on correlates of risk for postictal psychosis (PIP) suggest the value of a controlled study involving a relatively large number of patients. Methods The study population consisted of a consecutive seri
Autor:
Leslie S. Prichep, Kenneth Alper, E. Roy John, Jonathan D. Brodie, Raoul Sam Daruwala, Wilfred Günther
Publikováno v:
Psychiatry Research: Neuroimaging. 146:271-282
Positron emission tomography (PET) and quantitative electroencephalography (qEEG) were obtained in 15 normal male subjects with eyes closed at rest. Correlations between qEEG variables and regional metabolism were examined as an approach to investiga
Autor:
Kenneth Alper, Bryant Howard, Lev Sverdlov, Mitchell S. Rosenthal, Leslie S. Prichep, Sharon C. Kowalik, Henry Merkin, Mee Lee Tom, Erwin Roy John
Publikováno v:
Clinical Electroencephalography. 33:8-20
We previously described the existence of two quantitative EEG (QEEG) subtypes of cocaine dependent males, identified at baseline, displaying differential pronenessto relapse. The current study expands the population to include females and enhances th
Publikováno v:
American Journal on Addictions. 8:234-242
Ibogaine is an alkaloid with putative effect in acute opioid withdrawal. Thirty-three cases of treatments for the indication of opioid detoxiecation performed in non-medical settings under open label conditions are summarized involving an average dai